Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion

CHICAGO, IL / ACCESS Newswire / October 1, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an overview of its brand portfolio and the global markets it addresses. The portfolio comprises more than 15 proprietary brands and product lines and 10 branded generics across five product categories, sold in more than 40 countries through pharmacies, hospitals, retail chains and e-commerce. It is manufactured at GMP-certified facilities in Europe and the United States and supported by the Company's services in contract manufacturing, pharmaceutical distribution, telehealth and research and development. (link) (link) A Portfolio Built Across Five Categories

Each category addresses a distinct consumer or professional need and is supported by its own route to market: pharmacies and retail chains for nutraceuticals and consumer health, hospital procurement and national retailers for infection control, and direct-to-consumer channels in the United States. Most products are developed and manufactured within the Company, which it believes supports control over quality, cost and speed to market.